MAXERAN LIQ DIN 02099160
Status: Cancelled Post Market
Holder: HOECHST MARION ROUSSEL CANADA INC.
Molecule: METOCLOPRAMIDE HYDROCHLORIDE
Health Canada record
| Active ingredient(s) | METOCLOPRAMIDE HYDROCHLORIDE 1 MG |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A03FA01 METOCLOPRAMIDE |
| Original market date | 31-Dec-1995 |
| Current status date | 28-Jul-2000 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METOCLOPRAMIDE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02517809 | MAR-METOCLOPRAMIDE | MARCAN PHARMACEUTICALS INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Approved |
| 02517795 | MAR-METOCLOPRAMIDE | MARCAN PHARMACEUTICALS INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Marketed |
| 02185431 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION | SANDOZ CANADA INCORPORATED | Liquid | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Marketed |
| 02531747 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION | BAXTER CORPORATION | Solution | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Marketed |
| 02243563 | METOCLOPRAMIDE INJECTION USP | OMEGA LABORATORIES LIMITED | Solution | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Marketed |
| 02510790 | PMS-METOCLOPRAMIDE HYDROCHLORIDE INJECTION | PHARMASCIENCE INC | Solution | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Marketed |
| 02230433 | PMS-METOCLOPRAMIDE ORAL SOLUTION | PHARMASCIENCE INC | Solution | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Marketed |
| 02230431 | PMS-METOCLOPRAMIDE TABLETS | PHARMASCIENCE INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Marketed |
| 02548755 | PRZ-METOCLOPRAMIDE | PHARMARIS CANADA INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Marketed |
| 02548747 | PRZ-METOCLOPRAMIDE | PHARMARIS CANADA INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Marketed |
| 00842834 | APO-METOCLOP TAB 10MG | APOTEX INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Dormant |
| 00842826 | APO-METOCLOP TAB 5MG | APOTEX INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Dormant |
| 00572268 | MAXERAN 5MG TAB | LABS NORDIC LABORATORIES INC. - SUBSIDARY OF M.M.D.C. | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02099209 | MAXERAN-10 (10MG TABLET) | HOECHST MARION ROUSSEL CANADA INC. | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02099195 | MAXERAN-5 (5MG TABLET) | HOECHST MARION ROUSSEL CANADA INC. | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02197480 | METOCLOPRAMIDE HYDROCHLORIDE INJECTION HS | BIONICHE PHARMA (CANADA) LTD | Liquid | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 00870994 | METOCLOPRAMIDE TAB 10MG | PRO DOC LIMITEE | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00871001 | METOCLOPRAMIDE TAB 5MG | PRO DOC LIMITEE | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02143283 | NU-METOCLOPRAMIDE-TAB 10MG | NU-PHARM INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02143275 | NU-METOCLOPRAMIDE-TAB 5MG | NU-PHARM INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02500051 | PMS-METOCLOPRAMIDE HYDROCHLORIDE ORAL SOLUTION | PHARMASCIENCE INC | Solution | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
| 02500043 | PMS-METOCLOPRAMIDE HYDROCHLORIDE TABLETS | PHARMASCIENCE INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02500035 | PMS-METOCLOPRAMIDE HYDROCHLORIDE TABLETS | PHARMASCIENCE INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
| 02230432 | PMS-METOCLOPRAMIDE TABLETS | PHARMASCIENCE INC | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Dormant |
| 01913263 | REGLAN INJ 5MG/ML | AYERST LABORATORIES | Liquid | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02043556 | REGLAN INJECTABLE LIQ 5MG/ML | WYETH-AYERST CANADA INC. | Liquid | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02043548 | REGLAN SYR 1MG/ML | WYETH-AYERST CANADA INC. | Syrup | METOCLOPRAMIDE HYDROCHLORIDE 1 MG | Cancelled Post Market |
| 01913891 | REGLAN SYRUP 1MG/ML | AYERST LABORATORIES | Syrup | METOCLOPRAMIDE HYDROCHLORIDE 1 MG | Cancelled Post Market |
| 01913913 | REGLAN TAB 10MG | AYERST LABORATORIES | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02043521 | REGLAN TAB 10MG | WYETH-AYERST CANADA INC. | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 01913905 | REGLAN TAB 5MG | AYERST LABORATORIES | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02043513 | REGLAN-5 TAB 5MG | WYETH-AYERST CANADA INC. | Tablet | METOCLOPRAMIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
International API supply for METOCLOPRAMIDE HYDROCHLORIDE
3 active FDA Drug Master Files.
Request a quote for MAXERAN LIQ